Amphoraxe Life Sciences Inc.
We develop alternatives to conventional antibiotics to replace ineffective or restricted drugs. Our beachhead market is poultry farming applications.
We develop alternatives to antibiotics to replace ineffective or restricted drugs on the market.
We have identified and validated the poultry sector as an early revenue generator and a valuable testbed for human drugs.
Within five years, we aim to reach our beachhead market of poultry production in Canada. We will then quickly expand to the US and beyond.
As our assets successfully emerge, they will be out-licensed to biopharma companies.